oxonic acid has been researched along with Adenocarcinoma, Alveolar in 3 studies
Oxonic Acid: Antagonist of urate oxidase.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harada, H | 1 |
Nishio, M | 1 |
Murakami, H | 1 |
Ohyanagi, F | 1 |
Kozuka, T | 1 |
Ishikura, S | 1 |
Naito, T | 1 |
Kaira, K | 1 |
Takahashi, T | 1 |
Horiike, A | 1 |
Nishimura, T | 1 |
Yamamoto, N | 1 |
Kobayashi, S | 1 |
Fujino, N | 1 |
Suzuki, S | 1 |
Yanai, M | 1 |
Arai, W | 1 |
Hosoya, Y | 1 |
Hyodo, M | 1 |
Yokoyama, T | 1 |
Saito, S | 1 |
Kurasina, K | 1 |
Aoki, T | 1 |
Yasuda, Y | 1 |
Nagai, H | 1 |
Tamada, K | 1 |
1 trial available for oxonic acid and Adenocarcinoma, Alveolar
Article | Year |
---|---|
Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Antineoplastic Combined Chemothera | 2013 |
2 other studies available for oxonic acid and Adenocarcinoma, Alveolar
Article | Year |
---|---|
Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine).
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung | 2009 |
[Every-other-day TS-1 administration for recurrent or non-curative advanced gastric carcinoma].
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring C | 2002 |